New Data on Aliskiren Provoke Debate
This is a discussion on New Data on Aliskiren Provoke Debate within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; Aliskiren, a new direct renin inhibitor, reduced blood pressure to a greater degree than one of the usually recommended first-...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
01-19-2009, 08:43 PM
|
|||
|
|||
New Data on Aliskiren Provoke Debate
Aliskiren, a new direct renin inhibitor, reduced blood pressure to a greater degree than one of the usually recommended first-line agents, hydrochlorothiazide, in a new study. But there are a number of criticisms of the trial, including the assertion that the diuretic is not the ideal comparator.
Heartwire More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Lifestyle, Not Drugs, for Preventing Type 2 Diabetes: "Gladiatorial" Debate Concludes | industry_news | Other Clinical Pharmacy News | 0 | 09-11-2008 07:25 PM |
| Alabama "Obesity Penalty" Stirs Debate | industry_news | Other Clinical Pharmacy News | 0 | 08-26-2008 03:45 PM |
| Cardiologists Put Their Oar Into Rocky SEAS and Debate the Results | industry_news | Other Clinical Pharmacy News | 0 | 07-25-2008 02:34 PM |
| Combination of Gene Expression Data With Clinical Data Best Predicts Survival in Lung Adenocarcinoma | industry_news | Other Clinical Pharmacy News | 0 | 07-22-2008 09:15 PM |
| Screening for Risk Factors or Detecting Disease? DEBATE Divides the CV Community | industry_news | Other Clinical Pharmacy News | 0 | 07-22-2008 02:14 PM |
© 2008 DrugManagementForum™ powered by |
 |